HomeABCZF • OTCMKTS
add
Abcam Ord Shs
Previous close
$22.25
Year range
$5.00 - $23.80
Market cap
2.65B GBP
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (GBP) | Jun 2023info | Y/Y change |
|---|---|---|
Revenue | 101.60M | — |
Operating expense | 58.85M | — |
Net income | 8.40M | — |
Net profit margin | 8.27 | — |
Earnings per share | — | — |
EBITDA | 29.25M | — |
Effective tax rate | 28.21% | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Jun 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 79.00M | — |
Total assets | 1.03B | — |
Total liabilities | 307.90M | — |
Total equity | 719.20M | — |
Shares outstanding | 229.20M | — |
Price to book | 7.09 | — |
Return on assets | 4.53% | — |
Return on capital | 4.97% | — |
Cash Flow
Net change in cash
| (GBP) | Jun 2023info | Y/Y change |
|---|---|---|
Net income | 8.40M | — |
Cash from operations | 13.65M | — |
Cash from investing | -10.50M | — |
Cash from financing | -5.90M | — |
Net change in cash | -5.00M | — |
Free cash flow | 15.85M | — |
About
Abcam Limited is a producer, distributor and seller of protein research tools operating worldwide from 13 locations with 1,800 employees of which 400 work in Research and Development. Abcam was listed on the Nasdaq and the London Stock Exchange until it was acquired by Danaher Corporation in 2023. Wikipedia
Founded
1998
Website
Employees
1,760
